Coronavirus cases in the world have crossed 3.7 million with 2.5 lack deaths globally. Scientists all over the world are racing against the time to develop a vaccine for Coronavirus. There are over 75 coronavirus vaccine candidates out of which only a few are under the trail.
China is in Phase-II of developing CanSino’s Ad5-nCoV. This vaccine contains common adenovirus, with Coronavirus-like spike protein to generate an immune response. Fever is a known side effect of the CanSiino vaccine.
U.S based biotech firm Moderna Therapeutics has developed an mRNA vaccine that contains genetic material from coronavirus to develop immunity.
Another American company, Innovio Pharmaceuticals, has developed a DNA-based vaccine INO-4800. INO-800 can increase the production of antibodies that are known to fight Coronavirus.
Oxford university’s ChAdOx1 vaccine grabbed the headlines after the phase-I trials on humans started. If trials come out to be a success then this Oxford-developed vaccine can hit the markets as early as September.
Chinese company, Sinovac, has developed PiCoVacc. PiCoVacc vaccine contains an inactive SARS-Cov-2 to generate an immune response.
Coronavirus vaccine is estimated to be available in markets in the next 12-18 months.